Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan C Lansing

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Annual Review of Biophysics and Biomolecular Structure|May 4, 2002
Magnetic resonance studies of the bacteriorhodopsin pump cycleJudith Herzfeld, Jonathan C Lansing
Journal of Biomolecular NMR|June 12, 2013
Fast and accurate fitting of relaxation dispersion data using the flexible software package GLOVEKenji Sugase, Tsuyoshi Konuma, Jonathan C Lansing, et al.
Biochemistry|March 26, 2003
Solid-state NMR investigation of the buried X-proline peptide bonds of bacteriorhodopsinJonathan C Lansing, Jingui G Hu, Marina Belenky, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2005
Defining the role of active-site loop fluctuations in dihydrofolate reductase catalysisDan McElheny, Jason R Schnell, Jonathan C Lansing, et al.
Journal of the American Chemical Society|November 6, 2003
High-frequency dynamic nuclear polarization in MAS spectra of membrane and soluble proteinsMelanie Rosay, Jonathan C Lansing, Kristin C Haddad, et al.
Biochemistry|January 10, 2002
Chromophore distortions in the bacteriorhodopsin photocycle: evolution of the H-C14-C15-H dihedral angle measured by solid-state NMRJonathan C Lansing, Morten Hohwy, Christopher P Jaroniec, et al.
Plos One|August 1, 2017
High-resolution physicochemical characterization of different intravenous immunoglobulin productsNathaniel Washburn, Robin Meccariello, Shaohui Hu, et al.
Journal of Pharmacy Practice|August 30, 2017
Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple SclerosisChristine Bell, James Anderson, Tanmoy Ganguly, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2015
Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activityNathaniel Washburn, Inessa Schwab, Daniel Ortiz, et al.
Nature Biotechnology|April 26, 2008
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsMarco Guerrini, Daniela Beccati, Zachary Shriver, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annual Review of Biophysics and Biomolecular Structure|May 4, 2002
Magnetic resonance studies of the bacteriorhodopsin pump cycleJudith Herzfeld, Jonathan C Lansing
Journal of Biomolecular NMR|June 12, 2013
Fast and accurate fitting of relaxation dispersion data using the flexible software package GLOVEKenji Sugase, Tsuyoshi Konuma, Jonathan C Lansing, et al.
Biochemistry|March 26, 2003
Solid-state NMR investigation of the buried X-proline peptide bonds of bacteriorhodopsinJonathan C Lansing, Jingui G Hu, Marina Belenky, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2005
Defining the role of active-site loop fluctuations in dihydrofolate reductase catalysisDan McElheny, Jason R Schnell, Jonathan C Lansing, et al.
Journal of the American Chemical Society|November 6, 2003
High-frequency dynamic nuclear polarization in MAS spectra of membrane and soluble proteinsMelanie Rosay, Jonathan C Lansing, Kristin C Haddad, et al.
Biochemistry|January 10, 2002
Chromophore distortions in the bacteriorhodopsin photocycle: evolution of the H-C14-C15-H dihedral angle measured by solid-state NMRJonathan C Lansing, Morten Hohwy, Christopher P Jaroniec, et al.
Plos One|August 1, 2017
High-resolution physicochemical characterization of different intravenous immunoglobulin productsNathaniel Washburn, Robin Meccariello, Shaohui Hu, et al.
Journal of Pharmacy Practice|August 30, 2017
Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple SclerosisChristine Bell, James Anderson, Tanmoy Ganguly, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2015
Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activityNathaniel Washburn, Inessa Schwab, Daniel Ortiz, et al.
Nature Biotechnology|April 26, 2008
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsMarco Guerrini, Daniela Beccati, Zachary Shriver, et al.
Pageof 2